A curated collection of AI resources, tools, guides, and industry insights to supplement the New Horizons: AI Adoption in Pharma microsite. Explore the latest in artificial intelligence — from foundational learning to pharma-specific applications.
Artificial intelligence is evolving rapidly, bringing with it deployment challenges, cost and energy concerns, and regulatory shifts. Yet there is a clear path to value.
A landmark peer-reviewed article from Nature Medicine examining the role of large language models and AI in healthcare and pharmaceutical settings.
McKinsey's annual global survey on AI adoption, trends, and business impact — essential reading for pharma leaders navigating AI transformation.
Leadership, culture, and workforce transformation are the critical success factors — not the technology itself.
The executive's playbook for artificial intelligence in business: Size the AI opportunity in your industry using our market data, understand the data and technology you need to seize it, and learn AI best practices to realize the value.
Bain partners unveil a three-part playbook to transform customer experience and drive sustainable growth.
The Strategic CIO's Generative AI Playbook helps CIOs drive secure, scalable AI adoption and measurable business impact.
The IBM Institute for Business Value uses data-driven research and expert analysis to deliver thought-provoking insights to leaders on the emerging trends that will determine future success.'
This toolkit provides a one-stop place for corporate executives to identify and understand the multiple and complex issues that AI raises for their business and society. It provides a practical set of tools.
Gartner's comprehensive AI research hub — covering trends, hype cycles, strategic frameworks, and best practices for enterprise AI adoption.
A practical online learning programme covering AI applications in medical diagnosis, prognosis, and treatment — ideal for pharma professionals building AI literacy.
EY's expert analysis on how artificial intelligence is reshaping drug discovery, clinical trials, and commercial operations in the pharmaceutical industry.
The World Health Organization's guidance on the ethical and responsible use of AI in health and pharmaceutical contexts.